ASCL2 is a basic helix-loop-helix transcription factor that functions as a critical regulator of stem cell maintenance and lineage differentiation across multiple tissues. As a DNA-binding protein, ASCL2 recognizes E-box motifs and likely operates as a heterodimer with other bHLH proteins, potentially functioning as a pioneer transcription factor to remodel chr11 accessibility 1. In intestinal crypts, ASCL2 is required for intestinal stem cell (ISC) renewal, working synergistically with TCF4/β-catenin signaling to maintain stem cell characteristics and activate target genes including SOX9 2. ASCL2 expression serves as a marker of stem-like cancer cells with metastatic potential; high ASCL2-expressing cells in colorectal cancer correlate with organ-specific metastasis capacity 3. During neuroendocrine trans-differentiation in prostate cancer, ASCL2 defines a distinct lineage separate from ASCL1-expressing cells, suggesting lineage-specific transcriptional control 4. In small cell lung cancer variants, ASCL2 functions as a dependency in POU2F3-expressing tuft cell-like tumors 5. ASCL2 is also essential for trophoblast development; as an upstream regulator of extravillous trophoblast specification, ASCL2 expression links to pregnancy outcomes 6. Mechanistically, the chr11 regulator HMGA1 directly induces ASCL2 expression through histone mark recruitment, establishing ASCL2 as a critical node in Wnt-driven colon tumorigenesis 1. These findings position ASCL2 as a master regulator of stemness, differentiation, and cancer phenotypes.